Advertisement
Research Article Free access | 10.1172/JCI108965
The Cardiovascular Division of the Department of Medicine, Harvard Medical School and Peter Bent Brigham Hospital, Boston, Massachusetts 02115
The Cardiovascular Division of the Department of Pathology, Harvard Medical School and Peter Bent Brigham Hospital, Boston, Massachusetts 02115
Find articles by Maclean, D. in: JCI | PubMed | Google Scholar
The Cardiovascular Division of the Department of Medicine, Harvard Medical School and Peter Bent Brigham Hospital, Boston, Massachusetts 02115
The Cardiovascular Division of the Department of Pathology, Harvard Medical School and Peter Bent Brigham Hospital, Boston, Massachusetts 02115
Find articles by Fishbein, M. in: JCI | PubMed | Google Scholar
The Cardiovascular Division of the Department of Medicine, Harvard Medical School and Peter Bent Brigham Hospital, Boston, Massachusetts 02115
The Cardiovascular Division of the Department of Pathology, Harvard Medical School and Peter Bent Brigham Hospital, Boston, Massachusetts 02115
Find articles by Braunwald, E. in: JCI | PubMed | Google Scholar
The Cardiovascular Division of the Department of Medicine, Harvard Medical School and Peter Bent Brigham Hospital, Boston, Massachusetts 02115
The Cardiovascular Division of the Department of Pathology, Harvard Medical School and Peter Bent Brigham Hospital, Boston, Massachusetts 02115
Find articles by Maroko, P. in: JCI | PubMed | Google Scholar
Published March 1, 1978 - More info
The results of experiments with indirect methods have suggested that various interventions reduce infarct size after coronary artery occlusion. To determine and quantify directly both the short- and long-term effects of several interventions on myocardial salvage without relying on indirect methods, the left coronary artery was occluded in 880 rats; they were then given either no treatment or one of the following interventions: (a) hyaluronidase, an enzyme that hydrolyzes interstitial glycoproteins, 1,500 National Formulary (NF) U/kg i.v. 5 min and 24 h after occlusion; (b) cobra venom factor, a protein that depletes the third component of complement, 20 U/kg i.v. 5 min after occlusion; (c) a glucocorticoid: hydrocortisone, 50 mg/kg i.v. 5 min after occlusion; or the five-fold more potent methylprednisolone (MP): (i) 50 mg/kg i.v. 5 min after occlusion or (ii) 50 mg/kg i.v. 5 min after occlusion followed by 50 mg/kg i.m. 3, 6, and 24 h after occlusion; or (d) reserpine, an agent that depletes the heart of catecholamines, 0.5 mg/kg i.m. once on each of the 3 days before occlusion. The animals were sacrificed either 2 days after occlusion, i.e., at the time of peak necrosis, or after 3 wk, i.e., after the infarct was completely healed. The amount of preserved myocardium was then assessed by two independent techniques: planimetric measurement of serial histologic sections and creatine kinase activity of the whole left ventricle. The amount of normal myocardium preserved at 21 days postocclusion was significantly increased, by 22.3±7.8% (P < 0.025) after the administration of hyaluronidase, by 25.3±5.8% (P < 0.005) after cobra venom factor, by 14.5±6.9% (P < 0.05) after hydrocortisone, by 20.8±8.2% (P < 0.025) after the single dose of MP, by 20.9±3.9% (P < 0.001) after the four doses of MP, and by 10.2±3.7% (P < 0.05) as a result of pretreatment with reserpine. The four doses of MP significantly thinned the infarct—by 25.6±2.9% (P < 0.001)—and although ventricular rupture did not occur, the intervention caused distension of the left ventricle as a result of stretching of the infarcted tissue during scar formation. Thus, myocardium acutely jeopardized by ischemia can be preserved on a long-term basis.
Images.